(Q36417137)

14 August 2017

1 reference

title

Should postprandial hyperglycaemia in prediabetic and type 2 diabetic patients be treated? (English)

1 reference

14 August 2017

1 reference

Guillaume Charpentier

1

1 reference

14 August 2017

Jean-Pierre Riveline

2

1 reference

14 August 2017

Dured Dardari

3

1 reference

14 August 2017

Michel Varroud-Vial

4

1 reference

14 August 2017

1 January 2006

1 reference

14 August 2017

1 reference

14 August 2017

66

1 reference

14 August 2017

3

1 reference

14 August 2017

273-286

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200666030-00001

14 August 2017

0 references

cites work

Sucrose malabsorption in man after ingestion of alpha-glucosidehydrolase inhibitor

1 reference

12 December 2020

The effect of acarbose on insulin resistance in obese hypertensive subjects with normal glucose tolerance: a randomized controlled study

1 reference

12 December 2020

Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women

1 reference

12 December 2020

Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes.

1 reference

12 December 2020

[Treatment recommendations for type 2 diabetes. Agence Française de Sécurité Sanitaire des Produits de Santé (AFSSAPS)]

1 reference

12 December 2020

Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals.

1 reference

12 December 2020

Effect of alpha-glucosidehydrolase inhibition and intestinal absorption of sucrose, water, and sodium in man

1 reference

12 December 2020

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

12 December 2020

Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality

1 reference

12 December 2020

Efficacy and tolerability of acarbose in Asian patients with type 2 diabetes inadequately controlled with diet and sulfonylureas

1 reference

12 December 2020

Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

1 reference

12 December 2020

Survival time after onset of diabetes: 29-year follow-up mortality study in a diabetes cohort from a rural district

1 reference

12 December 2020

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria

1 reference

12 December 2020

What does postprandial hyperglycaemia mean?

1 reference

12 December 2020

Prognostic significance of endothelial dysfunction in hypertensive patients

1 reference

12 December 2020

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial

1 reference

12 December 2020

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

1 reference

12 December 2020

Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients

1 reference

12 December 2020

Effect of acarbose on postprandial lipid metabolism in type 2 diabetes mellitus

1 reference

12 December 2020

The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: the AACE system of intensive diabetes self-management--2000 update

1 reference

12 December 2020

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

12 December 2020

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group

1 reference

12 December 2020

Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release

1 reference

12 December 2020

Efficacy and safety of voglibose in comparison with acarbose in type 2 diabetic patients

1 reference

12 December 2020

Postprandial blood glucose. American Diabetes Association

1 reference

12 December 2020

Acarbose slows progression of intima-media thickness of the carotid arteries in subjects with impaired glucose tolerance

1 reference

12 December 2020

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

12 December 2020

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

12 December 2020

The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years

1 reference

12 December 2020

Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients

1 reference

12 December 2020

Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program

1 reference

12 December 2020

Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria.

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study

1 reference

12 December 2020

Glucagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-glucosidase inhibition (acarbose)

1 reference

12 December 2020

The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics

1 reference

12 December 2020

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

1 reference

12 December 2020

Beyond postprandial hyperglycaemia: metabolic factors associated with cardiovascular disease

1 reference

12 December 2020

Acarbose improves glycemic control in overweight type 2 diabetic patients insufficiently treated with metformin

1 reference

12 December 2020

[Strategies for care of the type 2 diabetic patient excluding care of complications. Recommendations of ANAES (National Agency for Health Accreditation and Evaluation March 2000]

1 reference

12 December 2020

Vascular dysfunction in diabetes mellitus

1 reference

12 December 2020

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study

1 reference

12 December 2020

Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study

1 reference

12 December 2020

Effect of glycemia on mortality in Pima Indians with type 2 diabetes

1 reference

12 December 2020

Acarbose controls postprandial hyperproinsulinemia in non-insulin dependent diabetes mellitus.

1 reference

12 December 2020

European study on dose-response relationship of acarbose as a first-line drug in non-insulin-dependent diabetes mellitus: efficacy and safety of low and high doses

1 reference

12 December 2020

Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Impaired glucose tolerance, Type II diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study

1 reference

12 December 2020

Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects

1 reference

12 December 2020

Review of acarbose therapeutic strategies in the long-term treatment and in the prevention of type 2 diabetes

1 reference

12 December 2020

NIDDM and its metabolic control predict coronary heart disease in elderly subjects

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

The prevention of type 2 diabetes mellitus: recent advances

1 reference

12 December 2020

Carotid artery stenosis is related to blood glucose level in an elderly Caucasian population: the Hoorn Study.

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients

1 reference

12 December 2020

Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve

1 reference

12 December 2020

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

1 reference

12 December 2020

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

1 reference

12 December 2020

Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level

1 reference

12 December 2020

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

12 December 2020

Acarbose improves indirectly both insulin resistance and secretion in obese type 2 diabetic patients.

1 reference

12 December 2020

Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose.

1 reference

12 December 2020

Effect of acarbose on insulin sensitivity in elderly patients with diabetes.

1 reference

12 December 2020

Efficacy and safety of acarbose add-on therapy in the treatment of overweight patients with Type 2 diabetes inadequately controlled with metformin: a double-blind, placebo-controlled study.

1 reference

12 December 2020

The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance

1 reference

12 December 2020

A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)

1 reference

12 December 2020

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.

1 reference

12 December 2020

Diabetes, asymptomatic hyperglycemia, and 22-year mortality in black and white men. The Chicago Heart Association Detection Project in Industry Study

1 reference

12 December 2020

Association of postprandial hypertriglyceridemia and carotid intima-media thickness in patients with type 2 diabetes.

1 reference

12 December 2020

Post-meal coagulation activation in diabetes mellitus: the effect of acarbose

1 reference

12 December 2020

Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect

1 reference

12 December 2020

Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study

1 reference

12 December 2020

Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investiga

1 reference

12 December 2020

The post-prandial state in Type 2 diabetes and endothelial dysfunction: effects of insulin aspart

1 reference

12 December 2020

Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study

1 reference

12 December 2020

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies

1 reference

12 December 2020

10.2165/00003495-200666030-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference